These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1311355)

  • 1. Processing of human cytomegalovirus envelope glycoproteins in and egress of cytomegalovirus from human astrocytoma cells.
    Kari B; Radeke R; Gehrz R
    J Gen Virol; 1992 Feb; 73 ( Pt 2)():253-60. PubMed ID: 1311355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stable constitutive expression of glycoprotein B (gpUL55) of human cytomegalovirus in permissive astrocytoma cells.
    Reis B; Bogner E; Reschke M; Richter A; Mockenhaupt T; Radsak K
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1371-9. PubMed ID: 8393078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrieval of human cytomegalovirus glycoprotein B from cell surface is not required for virus envelopment in astrocytoma cells.
    Jarvis MA; Fish KN; Söderberg-Naucler C; Streblow DN; Meyers HL; Thomas G; Nelson JA
    J Virol; 2002 May; 76(10):5147-55. PubMed ID: 11967330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A human cytomegalovirus glycoprotein complex designated gC-II is a major heparin-binding component of the envelope.
    Kari B; Gehrz R
    J Virol; 1992 Mar; 66(3):1761-4. PubMed ID: 1310777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cytomegalovirus glycoprotein-receptor interactions.
    Rasmussen L; Resta S; Merigan T
    Transplant Proc; 1991 Jun; 23(3 Suppl 3):60-3. PubMed ID: 1648838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human cytomegalovirus maturation by brefeldin A.
    Eggers M; Bogner E; Agricola B; Kern HF; Radsak K
    J Gen Virol; 1992 Oct; 73 ( Pt 10)():2679-92. PubMed ID: 1328480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Function of human cytomegalovirus glycoprotein B: syncytium formation in cells constitutively expressing gB is blocked by virus-neutralizing antibodies.
    Tugizov S; Navarro D; Paz P; Wang Y; Qadri I; Pereira L
    Virology; 1994 Jun; 201(2):263-76. PubMed ID: 8184537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure, composition and heparin binding properties of a human cytomegalovirus glycoprotein complex designated gC-II.
    Kari B; Gehrz R
    J Gen Virol; 1993 Feb; 74 ( Pt 2)():255-64. PubMed ID: 8381465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and immunological characterization of human cytomegalovirus gp55-116 (gB) expressed in insect cells.
    Wells DE; Vugler LG; Britt WJ
    J Gen Virol; 1990 Apr; 71 ( Pt 4)():873-80. PubMed ID: 2157800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The human cytomegalovirus glycoprotein B gene (ORF UL55) is expressed early in the infectious cycle.
    Smuda C; Bogner E; Radsak K
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1981-92. PubMed ID: 9266998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic processing of human cytomegalovirus glycoprotein B is dispensable for viral growth in culture.
    Strive T; Borst E; Messerle M; Radsak K
    J Virol; 2002 Feb; 76(3):1252-64. PubMed ID: 11773401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and composition of a family of human cytomegalovirus glycoprotein complexes designated gC-I (gB).
    Kari B; Liu YN; Goertz R; Lussenhop N; Stinski MF; Gehrz R
    J Gen Virol; 1990 Nov; 71 ( Pt 11)():2673-80. PubMed ID: 1701480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processing of human cytomegalovirus glycoprotein B in recombinant adenovirus-infected cells.
    Marshall GS; Fenger DP; Stout GG; Knights ME; Hunt LA
    J Gen Virol; 1996 Jul; 77 ( Pt 7)():1549-57. PubMed ID: 8757998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of an abundant disulfide-linked complex of glycoproteins in the envelope of guinea pig cytomegalovirus.
    Britt WJ; Harrison C
    Virology; 1994 Jun; 201(2):294-302. PubMed ID: 8184539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate.
    Compton T; Nowlin DM; Cooper NR
    Virology; 1993 Apr; 193(2):834-41. PubMed ID: 8384757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein gpTRL10 of human cytomegalovirus is dispensable for virus replication in human fibroblasts.
    Spaderna S; Hahn G; Mach M
    Arch Virol; 2004 Mar; 149(3):495-506. PubMed ID: 14991439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and processing of the major envelope glycoprotein of murine cytomegalovirus.
    Loh LC
    Virology; 1991 Jan; 180(1):239-50. PubMed ID: 1845824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytomegalovirus-mediated activation of pyrimidine biosynthesis drives UDP-sugar synthesis to support viral protein glycosylation.
    DeVito SR; Ortiz-Riaño E; Martínez-Sobrido L; Munger J
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):18019-24. PubMed ID: 25472841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphology and distribution of gp52 on extracellular human cytomegalovirus (HCMV) supports biochemical evidence that it represents the HCMV glycoprotein B.
    Stannard LM; Rider JR; Farrar GH
    J Gen Virol; 1989 Jun; 70 ( Pt 6)():1553-60. PubMed ID: 2543788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial patterns of protein expression in focal infections of human cytomegalovirus.
    Lam V; Boehme KW; Compton T; Yin J
    Biotechnol Bioeng; 2006 Apr; 93(6):1029-39. PubMed ID: 16506244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.